Showing results (81-90 of 725) with videos related to
Sort By:
Pageof 73
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|November 30, 1993
[The importance of therapy compliance in the treatment of arterial hypertension]B Waeber, G Heynen, H R BrunnerJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|July 1, 1994
The advantages of angiotensin II antagonismM Burnier, B Waeber, H R BrunnerEuropean Heart Journal|December 1, 1994
Dose-response relationships of ACE inhibitors and angiotensin II blockersH R Brunner, J Nussberger, B WaeberJournal of Cardiovascular Pharmacology|January 1, 1985
The present molecules of converting enzyme inhibitorsH R Brunner, J Nussberger, B WaeberClinical Science (London, England : 1979)|December 1, 1980
Converting enzyme inhibition during chronic angiotensin II infusion in rats: evidence against a non-angiotensin mechanismS C Textor, H R Brunner, H GavrasClinical Science and Molecular Medicine. Supplement|December 1, 1978
Redistribution of regional blood flow after administration of saralasin in salt-depleted dogsC S Liang, H Gavras, H R BrunnerHypertension (Dallas, Tex. : 1979)|March 1, 1981
Converting enzyme inhibition during chronic angiotensin II infusion in rats. Evidence against a nonangiotensin mechanismS C Textor, H R Brunner, H GavrasHypertension (Dallas, Tex. : 1979)|July 1, 1981
Role of reactive hyperreninemia in blood pressure changes induced by sodium depletion in patients with refractory hypertensionH Gavras, B Waeber, G R Kershaw, et al.Annals of Internal Medicine|January 1, 1979
Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patientsH R Brunner, H Gavras, B Waeber, et al.Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1985
Double-blind comparison of indapamide with a placebo in hypertensive patients treated by practicing physiciansM D Schaller, B Waeber, H R BrunnerPageof 73